BN

Unlocking Success – Key Insights for Brookfield Investors

A strong performer from today's morning trading session is Brookfield, whose shares rose 4.2% to $49.11 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

Brookfield's Valuation Is in Line With Its Sector Averages:

Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. The company belongs to the Real Estate sector, which has an average price to earnings (P/E) ratio of 30.37 and an average price to book (P/B) ratio of 2.09. In contrast, Brookfield has a trailing 12 month P/E ratio of 86.2 and a P/B ratio of 1.8.

When we divideBrookfield's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.16, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

A Declining EPS Growth Trend and Negative Cash Flows:

2018 2019 2020 2021 2022 2023
Revenue (M) $56,771 $67,826 $62,752 $75,731 $92,769 $95,924
Net Margins 13% 8% 1% 16% 6% 5%
Net Income (M) $7,488 $5,354 $707 $12,388 $5,195 $5,105
Net Interest Expense (M) $4,854 $7,227 $7,213 $7,604 $10,702 n/a
Depreciation & Amort. (M) $3,102 $4,876 $5,791 $6,437 $7,683 $9,075
Earnings Per Share $3.4 $1.73 -$0.12 $2.39 $1.19 $0.61
EPS Growth n/a -49.12% -106.94% 2091.67% -50.21% -48.74%
Free Cash Flow (M) -$70,658 -$56,330 -$18,531 -$52,957 -$57,291 $6,467
CAPEX (M) $75,817 $62,658 $26,872 $60,831 $66,042 n/a
Total Debt (M) $5,969 $7,083 $9,077 $9,963 $11,390 $11,984
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS